Selling life-style drugs for supportive care in most cancers: MASCC endorsement of the ACLM most cancers threat discount and survivorship toolkit

This web page was created programmatically, to learn the article in its authentic location you may go to the hyperlink bellow:
https://pubmed.ncbi.nlm.nih.gov/41579219/%3Futm_source%3DSimplePie%26utm_medium%3Drss%26utm_campaign%3Dpubmed-2%26utm_content%3D1pq-4TZ0w1pIimA2HHLJZYTkSjaU335U-aRSFRxJ31Blahz9sN%26fc%3D20220524061305%26ff%3D20260124125010%26v%3D2.18.0.post22%2B67771e2
and if you wish to take away this text from our website please contact us



Editorial


doi: 10.1007/s00520-026-10367-w.

Affiliations

Item in Clipboard

Editorial

Pamela Ok Ginex et al.


Support Care Cancer.


.

Abstract

Cancer survivors face most cancers and treatment-related well being challenges and are at elevated threat of growing different persistent illnesses, usually resulting in multimorbidity. Lifestyle drugs can cut back the chance and severity of as much as 80% of those persistent illnesses and are an vital part of survivorship care. Healthy life-style habits – reminiscent of a plant-forward weight loss plan, common train, and sustaining wholesome weight – enhance life expectancy in a normal inhabitants with compelling proof supporting the identical advantages amongst most cancers survivors. A brand new useful resource from the American College of Lifestyle Medicine (ACLM), the Lifestyle Medicine Cancer Risk Reduction and Survivorship Toolkit (LMCT), goals to beat limitations by offering accessible, evidence-based life-style drugs assets to be used on the level of care. To assist oncology healthcare professionals and most cancers survivors, MASCC has endorsed the ACLM Cancer Risk Reduction and Survivorship Toolkit. This editorial describes the LMCT and the way it may be a useful resource for most cancers supportive care.

PubMed Disclaimer

Conflict of curiosity assertion

Declarations. Ethics: Not relevant. Competing pursuits: The authors declare no competing pursuits.

References

    1. Aflague TF, Esquivel MK, Hammond Ok, Delos Reyes B, Kaholokula JK (2023) Traditional and new life-style interventions to forestall breast most cancers recurrence (TANICA): a qualitative research. Support Care Cancer 31(4):218.



      DOI

      PubMed



      PMC

    1. Bian Z, Zhang R, Yuan S, Fan R, Wang L, Larsson SC, Theodoratou E, Zhu Y, Wu S, Ding Y, Li X (2023) Healthy life-style and most cancers survival: a multinational cohort research. Int J Cancer 154:1709–1718



      DOI

    1. Cannioto RA, Attwood KM, Davis EW, Mendicino LA, Hutson A, Zirpoli GR, Tang L, Nair NM, Barlow W, Hershman DL, Unger JM, Moore HCF, Isaacs C, Hobday TJ, Hortobagyi GN, Gralow JR, Albain KS, Budd GT, Ambrosone CB (2023) Adherence to most cancers prevention life-style suggestions earlier than, throughout and a pair of years after remedy for high-risk breast most cancers. JAMA Netw Open 6(5):e2311673



      DOI

      PubMed



      PMC

    1. Chan RJ, Knowles R, Ashbury FD, Bowen J, Chan A, Chin M et al (2024) Supportive care 2030 motion: in direction of unifying ambitions for world excellence in supportive most cancers care-an worldwide Delphi research. EClinicalMedicine 76:102825



      DOI

      PubMed



      PMC

    1. Comander A, Frates B, Tollefson M (2021) Paving the trail to wellness for breast most cancers survivors: life-style drugs training and group interventions. Am J Lifestyle Med 15(3):242–248.



      DOI

      PubMed



      PMC

MeSH phrases